Skip to content

Air Products & Chemicals

US · APD #351 by market cap Listed 1970
278.12 -2.88 -1.02%
Live - 5344 symbols - heartbeat 80s ago · 2026-10-08 05:06
Pre-market 275.20 -1.05%
After-hours 278.12 0.00%
Overnight 277.29 -0.30%
Market cap
61.93B
P/E (TTM)
-1,324.38
P/B
4.46
EPS
-1.77
Reader sentiment Are you bullish or bearish on APD?

Anonymous reader poll. Unscientific, not investment advice.

✦ Quant Ownership Signal how this is computed

Distributing
  • The number of reporting institutions decreased by 4 in the most recent period (2026/Q3).
  • Total institutional ownership (as a % of shares) was little changed.

Institutional ownership

Held by institutions
92.29% -0.04pp
Institutions
1,976 -4
As of
2026/Q3 vs. prior period

Ownership vs. money flow

Diverging

Institutions trimmed shares last reporting period, and the stock has seen net inflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Holder types

Mutual Fund69.71%
Private Company6.80%
Public Company6.60%
Hedge Fund4.37%
Sovereign Wealth Fund2.14%
Government Pension Fund1.44%
Family Office/Trust0.55%
Insurance Company0.32%
Government0.10%
Other7.97%

Top holders

Capital Research 9.18%
BlackRock 8.23%
Vanguard Capital Management, LLC 7.09%
State Farm Mutual Automobile Insurance Company 5.32%
State Street Global Advisors 4.61%
Other 65.58%
Dodge & Cox 4.22%
Vanguard Portfolio Management, LLC 3.97%
Geode Capital Management, LLC 2.25%
Viking Global Investors LP 2.13%
Norges Bank Investment Management 2.10%

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 45 buys · 5 sells

NameRoleStake
Francesco Maione President of Americas 0.01%
Melissa Schaeffer Senior Vice President 0.01%
Ivo Bols President of Europe & Africa 0.01%
Bhavesh Patel Independent Director 0.00%
Wilbur Mok President of Asia 0.00%
Matthew Lepore Executive VP, General Counsel, Secretary & Chief Compliance Officer 0.00%
Victoria Brifo Chief Human Resources Officer 0.00%
William Pellicciotti Controller & Chief Accounting Officer 0.00%
Wayne Smith Independent Director 0.00%
Kurt Lefevere President of Asia 0.00%

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-09-29 Dennis Reilley Vice Chairman of Board Other Derivative Acquisition +17 --
2026-09-29 Andrew Evans Independent Director Other Derivative Acquisition +8 --
2026-09-29 Wayne Smith Independent Director Other Derivative Acquisition +33 --
2026-09-29 Alfred Stern Independent Director Other Derivative Acquisition +99 --
2026-09-29 Tonit Calaway Director Other Derivative Acquisition +20 --
2026-09-29 Bhavesh Patel Independent Director Other Derivative Acquisition +138 --
2026-09-29 Howard Ungerleider Director Other Derivative Acquisition +6 --
2026-09-29 Jessica Graziano Independent Director Other Derivative Acquisition +170 --
2026-08-17 Matthew Lepore Executive VP, General Counsel, Secretary & Chief Compliance Officer Sale to Issuer -418 $303.62
2026-06-29 Dennis Reilley Vice Chairman of Board Other Derivative Acquisition +17 --
2026-06-29 Andrew Evans Independent Director Other Derivative Acquisition +8 --
2026-06-29 Wayne Smith Independent Director Other Derivative Acquisition +34 --
2026-06-29 Alfred Stern Independent Director Other Derivative Acquisition +101 --
2026-06-29 Tonit Calaway Director Other Derivative Acquisition +20 --
2026-06-29 Bhavesh Patel Independent Director Other Derivative Acquisition +141 --
2026-06-29 Howard Ungerleider Director Other Derivative Acquisition +6 --
2026-06-29 Jessica Graziano Independent Director Other Derivative Acquisition +173 --
2026-04-30 Melissa Schaeffer Senior Vice President Open Market Disposition -2,714 $303.76
2026-03-30 Dennis Reilley Vice Chairman of Board Other Derivative Acquisition +16 --
2026-03-30 Andrew Evans Independent Director Other Derivative Acquisition +7 --

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-10-08 05:06:06 · For reference only, not investment advice and not tailored to your situation.